Immunotherapy for esophageal squamous cell carcinoma: a review-Reference-Cited by-同舟云学术

Immunotherapy for esophageal squamous cell carcinoma: a review

Published:2018 Issue:2 Volume:64 Page:46-53
ISSN:0016-2590
Container-title:FUKUSHIMA JOURNAL OF MEDICAL SCIENCE
language:en
Short-container-title:FJMS

Author:

Mimura Kosaku¹²³,Yamada Leo¹,Ujiie Daisuke¹,Hayase Suguru¹,Tada Takeshi¹,Hanayama Hiroyuki¹,Thar Min Aung Kyi¹,Shibata Masahiko¹²,Momma Tomoyuki¹,Saze Zenichiro¹,Ohki Shinji¹,Kono Koji¹

Affiliation:

1. Department of Gastrointestinal Tract Surgery, Fukushima Medical University

2. Department of Advanced Cancer Immunotherapy, Fukushima Medical University

3. Department of Progressive DOHaD Research, Fukushima Medical University

Publisher

The Fukushima Society of Medical Science

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/fms/64/2/64_2018-09/_pdf

Reference39 articles.

1. 3. Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol, 8: 545-553, 2007.

2. 4. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136: E359-386, 2015.

3. 5. Huppa JB, Davis MM. T-cell-antigen recognition and the immunological synapse. Nat Rev Immunol, 3: 973-983, 2003.

4. 6. Masopust D, Schenkel JM. The integration of T cell migration, differentiation and function. Nat Rev Immunol, 13: 309-320, 2013.

5. 7. Kono K, Iinuma H, Akutsu Y, et al. Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens. J Transl Med, 10: 141, 2012.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circ_0050444 represses esophageal squamous cell carcinoma progression through sponging miR-486-3p to upregulate C10orf91;Cell Cycle;2024-03-18

2. Delivery strategies of immunotherapies in the treatment of pancreatic cancer;Immune Landscape of Pancreatic Cancer Development and Drug Resistance;2024

3. Preventive Treatment with PD-1 Antibody Increases Tissue-resident Memory T Cells Infiltration and Delays Esophageal Carcinogenesis;Cancer Prevention Research;2023-10-19

4. Efficacy and adverse events of immune checkpoint inhibitors in esophageal cancer patients: Challenges and perspectives for immunotherapy;Asia-Pacific Journal of Clinical Oncology;2023-05-12

5. The Prognostic Significance of Nomogram-Based Pretreatment Inflammatory Indicators in Patients With Esophageal Squamous Cell Carcinoma Receiving Intensity-Modulated Radiotherapy;Cancer Control;2023-04